Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Non-Current Assets (2020 - 2026)

Maxcyte has reported Non-Current Assets over the past 6 years, most recently at $84.1 million for Q4 2025.

  • Quarterly Non-Current Assets rose 24.12% to $84.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $323.7 million through Dec 2025, up 8.41% year-over-year, with the annual reading at $84.1 million for FY2025, 24.12% up from the prior year.
  • Non-Current Assets was $84.1 million for Q4 2025 at Maxcyte, down from $88.8 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $88.8 million in Q3 2025 and troughed at $8.2 million in Q3 2021.
  • The 5-year median for Non-Current Assets is $52.4 million (2023), against an average of $51.5 million.
  • Year-over-year, Non-Current Assets soared 318.61% in 2022 and then decreased 13.18% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $13.7 million in 2021, then surged by 151.23% to $34.4 million in 2022, then surged by 127.06% to $78.1 million in 2023, then dropped by 13.18% to $67.8 million in 2024, then grew by 24.12% to $84.1 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Non-Current Assets are $84.1 million (Q4 2025), $88.8 million (Q3 2025), and $76.5 million (Q2 2025).